Tudor Investment Corp ET AL purchased a new position in shares of Amprius Technologies, Inc. (NYSE:AMPX – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 715,736 shares of the company’s stock, valued at approximately $7,530,000. Tudor Investment Corp ET AL owned about 0.55% of Amprius Technologies as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Bank of America Corp DE raised its holdings in shares of Amprius Technologies by 31.1% during the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock valued at $36,000 after buying an additional 3,055 shares in the last quarter. Ameritas Investment Partners Inc. boosted its stake in Amprius Technologies by 2,043.2% in the second quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock worth $40,000 after buying an additional 9,072 shares in the last quarter. Quarry LP purchased a new stake in Amprius Technologies in the third quarter worth approximately $42,000. Rhumbline Advisers grew its position in Amprius Technologies by 61.1% during the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after acquiring an additional 5,951 shares during the last quarter. Finally, Legal & General Group Plc grew its position in Amprius Technologies by 1,385.4% during the second quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock valued at $44,000 after acquiring an additional 9,684 shares during the last quarter. 5.04% of the stock is currently owned by hedge funds and other institutional investors.
Amprius Technologies Trading Up 2.6%
Amprius Technologies stock opened at $18.68 on Tuesday. The firm has a market cap of $2.56 billion, a P/E ratio of -54.92 and a beta of 3.04. Amprius Technologies, Inc. has a 1-year low of $1.97 and a 1-year high of $19.76. The firm has a 50-day moving average of $13.01 and a 200-day moving average of $11.62.
Insiders Place Their Bets
In other news, Director Kang Sun sold 61,251 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $10.16, for a total transaction of $622,310.16. Following the transaction, the director directly owned 1,342,400 shares of the company’s stock, valued at approximately $13,638,784. The trade was a 4.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Wen Hsuan Hsieh sold 413,146 shares of the company’s stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $18.44, for a total value of $7,618,412.24. Following the transaction, the director owned 44,444 shares of the company’s stock, valued at approximately $819,547.36. This represents a 90.29% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 2,929,357 shares of company stock valued at $37,783,110 in the last 90 days. 12.80% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the stock. B. Riley Financial boosted their price objective on shares of Amprius Technologies from $16.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, March 9th. Cantor Fitzgerald increased their target price on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, March 6th. Roth Mkm reiterated a “buy” rating and issued a $20.00 target price (up from $16.00) on shares of Amprius Technologies in a research report on Friday, March 6th. Oppenheimer reissued an “outperform” rating and issued a $17.00 price target on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Finally, William Blair restated an “outperform” rating on shares of Amprius Technologies in a research report on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $19.75.
Read Our Latest Stock Report on AMPX
About Amprius Technologies
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Featured Stories
Want to see what other hedge funds are holding AMPX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amprius Technologies, Inc. (NYSE:AMPX – Free Report).
Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
